Fengfei Wang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 6
- Cancer Cells and Metastasis 5
- Co-authors
- Erxi Wu (29 shared papers)Qingyong Ma (17 shared papers)Wanxing Duan (9 shared papers)Qinhong Xu (7 shared papers)Shuang Zhou (10 shared papers)Zheng Wang (5 shared papers)Jiangbo Liu (6 shared papers)Jiguang Ma (9 shared papers)
- Journals
- Current Medicinal Chemistry (5 papers)PLoS ONE (3 papers)Molecular Cancer (2 papers)Oncotarget (2 papers)Current Cancer Drug Targets (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Fengfei Wang
39 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 384
- Oncology 570
- Geriatrics and Gerontology 61
- Psychiatry and Mental health 194
- Molecular Biology 742
Countries citing papers authored by Fengfei Wang
This map shows the geographic impact of Fengfei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfei Wang more than expected).
Fields of papers citing papers by Fengfei Wang
This network shows the impact of papers produced by Fengfei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfei Wang. The network helps show where Fengfei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengfei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 165 | |
| 2 | 2013 | 137 | |
| 3 | 2013 | 116 | |
| 4 | 2009 | 115 | |
| 5 | 2012 | 107 | |
| 6 | 2016 | 95 | |
| 7 | 2011 | 91 | |
| 8 | 2013 | 88 | |
| 9 | 2018 | 81 | |
| 10 | 2013 | 67 | |
| 11 | 2012 | 58 | |
| 12 | 2011 | 56 | |
| 13 | 2011 | 53 | |
| 14 | 2001 | 52 | |
| 15 | 2018 | 46 | |
| 16 | 2018 | 44 | |
| 17 | 2008 | 41 | |
| 18 | 2014 | 39 | |
| 19 | 2002 | 36 | |
| 20 | 2019 | 36 |
About Fengfei Wang
Fengfei Wang is a scholar working on Molecular Biology, Oncology, Neurology, Cancer Research and Pathology and Forensic Medicine, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Cells and Metastasis (5 papers), Neuroblastoma Research and Treatments (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Cancer Mechanisms and Therapy (2 papers), Cardiovascular Health and Disease Prevention (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Cerebrovascular and Carotid Artery Diseases (2 papers). The work is most often cited by research in Cancer Research (384 citations), Oncology (570 citations), Geriatrics and Gerontology (61 citations), Psychiatry and Mental health (194 citations) and Molecular Biology (742 citations). Fengfei Wang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Erxi Wu, Qingyong Ma, Wanxing Duan, Qinhong Xu, Shuang Zhou, Zheng Wang, Jiangbo Liu, Jiguang Ma, Xuqi Li and Han Liu. Their work appears in journals such as Current Medicinal Chemistry, PLoS ONE, Molecular Cancer, Oncotarget and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.